198 related articles for article (PubMed ID: 33171023)
1. Clinical and Genomic Characteristics of Adult Diffuse Midline Glioma.
Park C; Kim TM; Bae JM; Yun H; Kim JW; Choi SH; Lee ST; Lee JH; Park SH; Park CK
Cancer Res Treat; 2021 Apr; 53(2):389-398. PubMed ID: 33171023
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study.
Liu C; Kuang S; Huang T; Wu J; Zhang L; Gong X
CNS Neurosci Ther; 2024 Apr; 30(4):e14730. PubMed ID: 38644565
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features and Prognosis of Diffuse Midline Glioma: A Series of 24 Cases.
Jang SW; Song SW; Kim YH; Cho YH; Hong SH; Kim JH; Ra YS; Chong S
Brain Tumor Res Treat; 2022 Oct; 10(4):255-264. PubMed ID: 36347640
[TBL] [Abstract][Full Text] [Related]
4. Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics.
Dono A; Takayasu T; Ballester LY; Esquenazi Y
J Clin Neurosci; 2020 Dec; 82(Pt A):1-8. PubMed ID: 33317715
[TBL] [Abstract][Full Text] [Related]
5. The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study.
Di Nunno V; Lombardi G; Simonelli M; Minniti G; Mastronuzzi A; Di Ruscio V; Corrà M; Padovan M; Maccari M; Caccese M; Simonetti G; Berlendis A; Farinotti M; Pollo B; Antonelli M; Di Muzio A; Dipasquale A; Asioli S; De Biase D; Tosoni A; Silvani A; Franceschi E
J Neurooncol; 2024 Mar; 167(1):145-154. PubMed ID: 38457090
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].
Li HN; Shan CG; Fan CZ; Cheng LN; Wu SG; Liu MT; Jiang GY; Li Z
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):192-198. PubMed ID: 30831644
[No Abstract] [Full Text] [Related]
7. Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience.
Neth BJ; Balakrishnan SN; Carabenciov ID; Uhm JH; Daniels DJ; Kizilbash SH; Ruff MW
J Neurooncol; 2022 Mar; 157(1):91-100. PubMed ID: 35076860
[TBL] [Abstract][Full Text] [Related]
8. Differences in survival prognosticators between children and adults with H3K27M-mutant diffuse midline glioma.
Gong X; Kuang S; Deng D; Wu J; Zhang L; Liu C
CNS Neurosci Ther; 2023 Dec; 29(12):3863-3875. PubMed ID: 37311690
[TBL] [Abstract][Full Text] [Related]
9. Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies.
Findlay IJ; De Iuliis GN; Duchatel RJ; Jackson ER; Vitanza NA; Cain JE; Waszak SM; Dun MD
Oncogene; 2022 Jan; 41(4):461-475. PubMed ID: 34759345
[TBL] [Abstract][Full Text] [Related]
10. MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II Trial.
Rodriguez D; Calmon R; Aliaga ES; Warren D; Warmuth-Metz M; Jones C; Mackay A; Varlet P; Le Deley MC; Hargrave D; Cañete A; Massimino M; Azizi AA; Saran F; Zahlmann G; Garcia J; Vassal G; Grill J; Peet A; Dineen RA; Morgan PS; Jaspan T
Radiology; 2022 Jul; 304(1):174-182. PubMed ID: 35412366
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Indicators for H3K27M-Mutant Diffuse Midline Glioma: A Population-Based Retrospective Surveillance, Epidemiology, and End Results Database Analysis.
Adhikari S; Bhutada AS; Ladner L; Cuoco JA; Entwistle JJ; Marvin EA; Rogers CM
World Neurosurg; 2023 Oct; 178():e113-e121. PubMed ID: 37423332
[TBL] [Abstract][Full Text] [Related]
12. Diffuse midline glioma with H3 K27M mutation: a comparison integrating the clinical, radiological, and molecular features between adult and pediatric patients.
Jiang H; Yang K; Ren X; Cui Y; Li M; Lei Y; Lin S
Neuro Oncol; 2020 May; 22(5):e1-e9. PubMed ID: 31504810
[TBL] [Abstract][Full Text] [Related]
13. [Diffuse midline glioma].
Saito R
No Shinkei Geka; 2022 Jan; 50(1):29-38. PubMed ID: 35169084
[TBL] [Abstract][Full Text] [Related]
14. Real-time drug testing of paediatric diffuse midline glioma to support clinical decision making: The Zurich DIPG/DMG centre experience.
Mueller T; Laternser S; Guerreiro Stücklin AS; Gerber NU; Mourabit S; Rizo M; Rushing EJ; Kottke R; Grotzer M; Krayenbühl N; Nazarian J; Mueller S
Eur J Cancer; 2023 Jan; 178():171-179. PubMed ID: 36455411
[TBL] [Abstract][Full Text] [Related]
15. National trends in the treatment of adult diffuse midline gliomas: a rare clinical scenario.
Desai J; Rajkumar S; Shepard MJ; Herbst J; Karlovits SM; Hasan S; Horne ZD; Wegner RE
J Neurooncol; 2024 Jun; 168(2):269-274. PubMed ID: 38630388
[TBL] [Abstract][Full Text] [Related]
16. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
[TBL] [Abstract][Full Text] [Related]
17. Diffuse midline glioma H3 K27M-mutant in adults: A report of six cases and literature review.
Alzoubi H; Maraqa B; Hasasna N; Giangaspero F; Antonelli M; Gianno F; Arcella A; Al-Hussaini M
Clin Neuropathol; 2021; 40(2):108-117. PubMed ID: 33191898
[TBL] [Abstract][Full Text] [Related]
18. Encouraging Clinical Evolution of a Pediatric Patient With Relapsed Diffuse Midline Glioma Who Underwent WT1-Targeting Immunotherapy: A Case Report and Literature Review.
Hashii Y; Oka Y; Kagawa N; Hashimoto N; Saitou H; Fukuya S; Kanegae M; Ikejima S; Oji Y; Ozono K; Tsuboi A; Sugiyama H
Front Oncol; 2020; 10():1188. PubMed ID: 32793489
[TBL] [Abstract][Full Text] [Related]
19. Predicting outcome in childhood diffuse midline gliomas using magnetic resonance imaging based texture analysis.
Szychot E; Youssef A; Ganeshan B; Endozo R; Hyare H; Gains J; Mankad K; Shankar A
J Neuroradiol; 2021 Jun; 48(4):243-247. PubMed ID: 32184119
[TBL] [Abstract][Full Text] [Related]
20. Radiologic findings and the molecular expression profile of diffuse midline glioma H3 K27M mutant.
Seong M; Kim ST; Noh JH; Kim YK; Kim HJ
Acta Radiol; 2021 Oct; 62(10):1404-1411. PubMed ID: 33175579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]